+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis



Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis



Pediatric Pulmonology 15(5): 287-291



Pseudomonas aeruginosa infection of the respiratory tract in patients with cystic fibrosis is a major determinant of morbidity and mortality. However, it has been postulated that the earliest phase of colonization is not associated with injury. To test this hypothesis we determined the association of the first recorded isolation of P. aeruginosa from the sputum on circulating markers of the inflammatory response in 6 patients with cystic fibrosis. At this time circulating C-reactive protein was increased in all 6 and neutrophil elastase alpha 1-antitrypsin complex (elastase-complex) was increased in 5 patients compared with healthy controls. This inflammatory response was associated with a reduction in the FEV1 and FVC of all patients [FEV1, 1.42 +/- 0.87 L (mean +/- SD) at first isolation vs. 2.08 +/- 0.74 L before isolation; P < 0.05; FVC, 1.94 +/- 0.93 L vs. 2.87 +/- 1.01 L, P < 0.05]. At a median interval of 10 months, 5 patients had raised titres of positive IgG antibody to P. aeruginosa, indicating significant exposure to this organism. At this time, lung function had returned to preinfection levels, whilst 3 patients showed continuing features of an inflammatory response, and the group mean value for elastase-complex was raised. Our findings demonstrate that at the time of first isolation of P. aeruginosa from the sputum of patients with cystic fibrosis, there is a concomitant systemic host response and an acute deterioration of pulmonary function.

(PDF emailed within 0-6 h: $19.90)

Accession: 046274842

Download citation: RISBibTeXText

PMID: 8327287

DOI: 10.1002/ppul.1950150505


Related references

Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatrica Scandinavica 72(2): 283-287, 1983

Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infection and Immunity 58(10): 3363-3368, 1990

Effect of Pseudomonas aeruginosa alginate expression of direct plating and culture of fresh cystic fibrosis sputum on to pseudomonas isolation agar containing subinhibitory concentrations of roxithromycin and rifampicin. Journal of Antimicrobial Chemotherapy 36(1): 231-236, 1995

Effect on Pseudomonas aeruginosa alginate expression of direct plating and culture of fresh cystic fibrosis sputum on to pseudomonas isolation agar containing subinhibitory concentrations of roxithromycin and rifampicin. Journal of Antimicrobial Chemotherapy 36(1): 231-236, 1995

Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules. Acs Infectious Diseases 4(5): 646-655, 2018

The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. Respiratory Medicine 87(8): 603-607, 1993

Pseudomonas aeruginosa infection in cystic fibrosis bactericidal effect of serum from normal individuals and patients with cystic fibrosis on pseudomonas aeruginosa strains from patients with cystic fibrosis or other diseases. Acta Pathologica et Microbiologica Scandinavica Section C Immunology 85(2): 107-114, 1977

Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients. Infection and Drug Resistance 7: 309-316, 2014

Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum. Proceedings of the National Academy of Sciences of the United States of America 112(13): 4110-4115, 2015

Rhamnolipid of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. Lancet 1(8540): 1026-1027, 1987

Pseudomonas aeruginosa infection in cystic fibrosis humoral and cellular immune responses against pseudomonas aeruginosa. Acta Pathologica et Microbiologica Scandinavica Section C Immunology 83(6): 459-468, 1975

Pseudomonas aeruginosa: can studies in engineered cells tell us why is it such a problem in people with cystic fibrosis? Focus on "Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa". American Journal of Physiology. Cell Physiology 297(2): C235-C237, 2009

Pseudomonas aeruginosa in the oral cavity and sputum of patients with cystic fibrosis. Oral Surgery Oral Medicine Oral Pathology 59(6): 590-594, 1985

Serotyping of Pseudomonas aeruginosa strains from sputum of patients with cystic fibrosis. Annali Sclavo; Rivista di Microbiologia E di Immunologia 24(3): 229-236, 1983

Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aeruginosa. Apmis 96(4): 294-298, 1988